Records containing: Respiratory Syncytial Virus Infection
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-02-08Synagis® Liquid 50mg, 100mg for Intramuscular Injection Special Investigation in Immunocompromised Children With Synagis®
-
CLINICAL_TRIALS study record update · 2015-07-10Post-Marketing Surveillance of Synagis in Korean Pediatric Patients Under the "New Drug Re-Examination"
-
CLINICAL_TRIALS study record update · 2014-09-03A One-Year Observational Study of Palivizumab in Infants at Risk for Respiratory Syncytial Virus Infection in Latin America
-
CLINICAL_TRIALS study record update · 2013-06-17Multi-center, Open-label, Uncontrolled Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical Conditions
-
CLINICAL_TRIALS study record update · 2012-04-23Observational Study of the Effectiveness of Synagis Immunoprophylaxis in Preterm Infants With High Risk of Severe Respiratory Syncytial Virus Infection
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2011-07-19A Prospective, Multicenter, Open-label, Non-comparative Study of Safety and Efficacy of Synagis in Children at High Risk of Severe Respiratory Syncytial Virus Infection in the Russian Federation
-
CLINICAL_TRIALS study record update · 2010-05-13Innate Immunity and RSV Infection in Children
-
CLINICAL_TRIALS study record update · 2008-03-04Prevention of RSV Infections in Bone Marrow Transplant Recipients